Primary |
Product Used For Unknown Indication |
56.1% |
Asthma |
6.1% |
Sinus Congestion |
4.5% |
Drug Abuse |
3.0% |
Multiple Allergies |
3.0% |
Nasal Obstruction |
3.0% |
Nasopharyngitis |
3.0% |
Sinusitis |
3.0% |
Antiallergic Therapy |
1.5% |
Antidepressant Therapy |
1.5% |
Anxiety |
1.5% |
Bronchitis |
1.5% |
Epilepsy |
1.5% |
Hypersensitivity |
1.5% |
Insomnia |
1.5% |
Malaise |
1.5% |
Nasal Congestion |
1.5% |
Nasal Decongestion Therapy |
1.5% |
Pain |
1.5% |
Post-traumatic Stress Disorder |
1.5% |
|
Panic Attack |
27.6% |
Anaphylactic Shock |
6.9% |
Headache |
6.9% |
Cerebrovascular Accident |
3.4% |
Colitis Ischaemic |
3.4% |
Drug Dependence |
3.4% |
Drug Diversion |
3.4% |
Dyspnoea |
3.4% |
Emotional Distress |
3.4% |
Febrile Convulsion |
3.4% |
Glaucoma |
3.4% |
Loss Of Consciousness |
3.4% |
Overdose |
3.4% |
Pyrexia |
3.4% |
Sinus Headache |
3.4% |
Sinusitis |
3.4% |
Syncope |
3.4% |
Therapeutic Response Unexpected |
3.4% |
Throat Tightness |
3.4% |
Tremor |
3.4% |
|
Secondary |
Product Used For Unknown Indication |
33.2% |
Asthma |
10.2% |
Sinus Congestion |
8.3% |
Anxiety |
4.4% |
Sinusitis |
4.4% |
Cough |
3.9% |
Seasonal Allergy |
3.9% |
Bronchitis |
3.4% |
Depression |
3.4% |
Epilepsy |
3.4% |
Insomnia |
3.4% |
Post-traumatic Stress Disorder |
2.9% |
Nasopharyngitis |
2.4% |
Antiallergic Therapy |
2.0% |
Gastric Disorder |
2.0% |
Nasal Decongestion Therapy |
2.0% |
Sedative Therapy |
2.0% |
Sleep Disorder Therapy |
2.0% |
Affective Disorder |
1.5% |
Antidepressant Therapy |
1.5% |
|
Drug Hypersensitivity |
15.4% |
Panic Attack |
13.5% |
Pyrexia |
13.5% |
Drug Dependence |
7.7% |
Off Label Use |
5.8% |
Sinus Headache |
5.8% |
Anaphylactic Shock |
3.8% |
Dyspnoea |
3.8% |
Emotional Distress |
3.8% |
Headache |
3.8% |
Loss Of Consciousness |
3.8% |
Pulmonary Arterial Hypertension |
3.8% |
Abnormal Dreams |
1.9% |
Atrial Fibrillation |
1.9% |
Blood Pressure Increased |
1.9% |
Colitis Ischaemic |
1.9% |
Drug Diversion |
1.9% |
Drug Ineffective |
1.9% |
Drug Screen Positive |
1.9% |
Epistaxis |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
34.9% |
Asthma |
8.7% |
Pain |
8.1% |
Gastrooesophageal Reflux Disease |
7.0% |
Headache |
5.5% |
Depression |
4.7% |
Anxiety |
4.1% |
Hypersensitivity |
3.6% |
Drug Use For Unknown Indication |
2.7% |
Hypertension |
2.3% |
Migraine |
2.2% |
Multiple Allergies |
2.2% |
Nasopharyngitis |
1.9% |
Seasonal Allergy |
1.9% |
Contraception |
1.8% |
Crohn's Disease |
1.8% |
Rheumatoid Arthritis |
1.8% |
Multiple Sclerosis |
1.7% |
Complex Regional Pain Syndrome |
1.5% |
Nausea |
1.5% |
|
Pulmonary Embolism |
13.1% |
Ventricular Septal Defect |
8.1% |
Vomiting |
8.1% |
Nausea |
7.1% |
Sinusitis |
7.1% |
Off Label Use |
6.1% |
Pain |
6.1% |
Drug Ineffective |
5.1% |
Pyrexia |
5.1% |
Headache |
4.0% |
Pruritus |
4.0% |
Therapeutic Response Unexpected |
4.0% |
Vision Blurred |
4.0% |
Oropharyngeal Pain |
3.0% |
Palpitations |
3.0% |
Thrombophlebitis Superficial |
3.0% |
Wrist Fracture |
3.0% |
Diarrhoea |
2.0% |
Feeling Jittery |
2.0% |
Hepatitis |
2.0% |
|
Interacting |
Product Used For Unknown Indication |
77.5% |
Oropharyngeal Pain |
5.0% |
Tongue Ulceration |
5.0% |
Laryngitis |
2.5% |
Nasal Obstruction |
2.5% |
Ovarian Cancer |
2.5% |
Plasma Cell Myeloma |
2.5% |
Sinus Congestion |
2.5% |
|
Headache |
25.0% |
Hypertension |
25.0% |
Skin Exfoliation |
25.0% |
Vomiting |
25.0% |
|